Kimberly Westrich

581 total citations
39 papers, 406 citations indexed

About

Kimberly Westrich is a scholar working on Economics and Econometrics, General Health Professions and Family Practice. According to data from OpenAlex, Kimberly Westrich has authored 39 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 15 papers in General Health Professions and 7 papers in Family Practice. Recurrent topics in Kimberly Westrich's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (10 papers) and Healthcare cost, quality, practices (9 papers). Kimberly Westrich is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (10 papers) and Healthcare cost, quality, practices (9 papers). Kimberly Westrich collaborates with scholars based in United States and United Kingdom. Kimberly Westrich's co-authors include Robert W. Dubois, Priscilla Velentgas, Nancy A Dreyer, Amanda Brummel, Michael A. Evans, Peter J. Neumann, Sean D. Sullivan, Anita Chawla, Josh J. Carlson and Adrian Towse and has published in prestigious journals such as Clinical Cancer Research, Journal of Occupational and Environmental Medicine and Value in Health.

In The Last Decade

Kimberly Westrich

33 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly Westrich United States 11 212 108 101 66 58 39 406
Ya-Seng Hsueh Australia 12 113 0.5× 100 0.9× 88 0.9× 51 0.8× 44 0.8× 29 393
Aine Heaney Australia 7 144 0.7× 110 1.0× 165 1.6× 69 1.0× 37 0.6× 9 337
Shivani Padmanabhan United Kingdom 4 115 0.5× 58 0.5× 96 1.0× 35 0.5× 68 1.2× 6 407
Ângela Jornada Ben Netherlands 12 80 0.4× 59 0.5× 34 0.3× 68 1.0× 51 0.9× 31 384
Brian K Solow United States 10 107 0.5× 70 0.6× 71 0.7× 118 1.8× 25 0.4× 14 399
Francisco Jódar‐Sánchez Spain 10 70 0.3× 107 1.0× 101 1.0× 37 0.6× 58 1.0× 28 361
J. Russell May United States 9 100 0.5× 66 0.6× 158 1.6× 19 0.3× 50 0.9× 25 425
Richard Lewis United Kingdom 10 105 0.5× 68 0.6× 83 0.8× 28 0.4× 30 0.5× 51 370
Cherie P. Brunker United States 9 164 0.8× 238 2.2× 130 1.3× 50 0.8× 44 0.8× 18 516
Joshua W. Devine United States 8 89 0.4× 38 0.4× 44 0.4× 41 0.6× 40 0.7× 23 302

Countries citing papers authored by Kimberly Westrich

Since Specialization
Citations

This map shows the geographic impact of Kimberly Westrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Westrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Westrich more than expected).

Fields of papers citing papers by Kimberly Westrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Westrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Westrich. The network helps show where Kimberly Westrich may publish in the future.

Co-authorship network of co-authors of Kimberly Westrich

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Westrich. A scholar is included among the top collaborators of Kimberly Westrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Westrich. Kimberly Westrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherman, Bruce W., et al.. (2025). The time is now: Addressing health inequities in the workforce. Journal of Managed Care & Specialty Pharmacy. 31(4). 421–427.
2.
Westrich, Kimberly, et al.. (2024). Improving access to gene therapies: a holistic view of current challenges and future policy solutions in the United States. Journal of Comparative Effectiveness Research. 13(12). e240098–e240098.
3.
Westrich, Kimberly, et al.. (2023). Payer perceptions and use of value assessment tools in the United States. Journal of Managed Care & Specialty Pharmacy. 29(5). 582–588. 1 indexed citations
4.
Sherman, Bruce W., et al.. (2022). Specialty drug and health care utilization vary by wage level in employer-sponsored health plans. Journal of Managed Care & Specialty Pharmacy. 28(8). 918–928. 5 indexed citations
5.
Oehrlein, Elisabeth, et al.. (2022). Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States. Journal of Managed Care & Specialty Pharmacy. 28(10). 1190–1196. 2 indexed citations
6.
Vyas, Ami, Stephen Kogut, Megha A. Parikh, et al.. (2022). Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims. Journal of Managed Care & Specialty Pharmacy. 28(8). 831–844. 12 indexed citations
7.
Patel, Palak, et al.. (2020). Improving patient-reported measures in oncology: a payer call to action. Journal of Managed Care & Specialty Pharmacy. 27(1). 118–126. 7 indexed citations
8.
Westrich, Kimberly, et al.. (2019). Reconciling the Seemingly Irreconcilable: How Much Are We Spending on Drugs?. Value in Health. 22(7). 792–798.
9.
Dubois, Robert W. & Kimberly Westrich. (2019). As Value Assessment Frameworks Evolve, Are They Finally Ready for Prime Time?. Value in Health. 22(9). 977–980. 18 indexed citations
10.
Lakdawalla, Darius, et al.. (2017). What do pharmaceuticals really cost in the long run?. PubMed. 23(8). 488–493. 3 indexed citations
11.
Abrahams, Edward, Alan Balch, Amy Myrdal Miller, et al.. (2017). Clinical Pathways: Recommendations for Putting Patients at the Center of Value-Based Care. Clinical Cancer Research. 23(16). 4545–4549. 14 indexed citations
12.
Westrich, Kimberly, et al.. (2017). Optimization of Medication Use at Accountable Care Organizations. Journal of Managed Care & Specialty Pharmacy. 23(10). 1054–1064. 11 indexed citations
13.
Westrich, Kimberly, et al.. (2017). Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures. Journal of Managed Care & Specialty Pharmacy. 23(2). 174–181. 9 indexed citations
14.
Westrich, Kimberly, et al.. (2016). The Central Role of Physician Leadership for Driving Change in Value-Based Care Environments. Journal of Managed Care & Specialty Pharmacy. 22(10). 1116–1122. 10 indexed citations
15.
Westrich, Kimberly, Jess Wilhelm, & Claudia L. Schur. (2016). Comparative effectiveness research in the USA: when will there be an impact on healthcare decision-making?. Journal of Comparative Effectiveness Research.
16.
Garrison, Louis P., Josh J. Carlson, Adrian Towse, et al.. (2015). Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.. PubMed. 21(9). 632–40. 47 indexed citations
17.
Dubois, Robert W., et al.. (2015). Solutions for filling gaps in accountable care measure sets.. PubMed. 21(10). 723–8. 1 indexed citations
18.
Dreyer, Nancy A, Priscilla Velentgas, Kimberly Westrich, & Robert W. Dubois. (2014). The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and Caution. Journal of Managed Care Pharmacy. 20(3). 301–308. 86 indexed citations
19.
Dubois, Robert W., et al.. (2014). Are ACOs Ready to be Accountable for Medication Use?. Journal of Managed Care Pharmacy. 20(1). 17–21. 10 indexed citations
20.
Cangelosi, Michael J., Sarah A. Bliss, Hong Chang, et al.. (2012). Imputing Productivity Gains From Clinical Trials. Journal of Occupational and Environmental Medicine. 54(7). 826–833. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya-Seng Hsueh Breakdown of academic impact, for papers by Aine Heaney Breakdown of academic impact, for papers by Shivani Padmanabhan Breakdown of academic impact, for papers by Ângela Jornada Ben Breakdown of academic impact, for papers by Brian K Solow Breakdown of academic impact, for papers by Francisco Jódar‐Sánchez Breakdown of academic impact, for papers by J. Russell May Breakdown of academic impact, for papers by Richard Lewis Breakdown of academic impact, for papers by Cherie P. Brunker Breakdown of academic impact, for papers by Joshua W. Devine
Rankless by CCL
2026